Targeting microglial P2Y12-receptor signalling attenuates neurodegeneration in experimental Parkinsons disease
Neuroinflammation is increasingly recognized as a determinant of dopaminergic neuron vulnerability in Parkinson's disease, yet the receptor-level mechanism